Technical Analysis for IXI - Ixico Plc

Grade Last Price % Change Price Change
F 51.0 6.25% 3.00
IXI closed up 6.25 percent on Thursday, December 2, 2021, on 20 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Dec 6
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical IXI trend table...

Date Alert Name Type % Chg
Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 6.25%
Expansion Breakdown Bearish Swing Setup 6.25%
New 52 Week Low Weakness 6.25%
Multiple of Ten Bearish Other 6.25%
Wide Bands Range Expansion 6.25%
Older End-of-Day Signals for IXI ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Ixico Plc Description

IXICO plc is a brain health company. The Company's brain health focus includes Alzheimer's disease, Huntington's disease, Parkinson's disease, behavioral health and adolescent mental health. It is a provider of clinical trials services to pharmaceutical companies. Its products include Assessa, mehealth, MyBrainBook and TrialTracker. Assessa is a decision-support tool for healthcare professionals looking to diagnose dementia and detect the underlying causes. mehealth is an online software for clinicians at the point-of-care to support decision making and improve the monitoring and treatment of patients. MyBrainBook is a digital platform to improve the quality of life and service delivery for people living with dementia and their supporters. TrialTracker is a Web-based system that allows users to track their imaging-based research study or clinical trial in real time. It is also collaborating with partners to develop companion digital health products.


Sector: Healthcare
Industry: Biotechnology
Keywords: Health Healthcare Software Pharmaceutical Quality Medicine Clinic Disease Monitoring Clinical Trial Imaging Rtt Eim Healthcare Professionals Mental Health Health Products Pharmaceutical Companies Alzheimer's Disease Dementia Aging Associated Diseases Learning Disabilities Parkinson's Disease Psychiatric Diagnosis

Is IXI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 115.0
52 Week Low 48.0
Average Volume 54,801
200-Day Moving Average 78.35
50-Day Moving Average 69.76
20-Day Moving Average 59.85
10-Day Moving Average 52.75
Average True Range 3.29
ADX 43.81
+DI 5.80
-DI 35.95
Chandelier Exit (Long, 3 ATRs) 61.02
Chandelier Exit (Short, 3 ATRs) 57.88
Upper Bollinger Bands 75.26
Lower Bollinger Band 44.44
Percent B (%b) 0.21
BandWidth 51.49
MACD Line -5.85
MACD Signal Line -5.25
MACD Histogram -0.6032
Fundamentals Value
Market Cap 24.02 Million
Num Shares 47.1 Million
EPS 2.00
Price-to-Earnings (P/E) Ratio 25.50
Price-to-Sales 5.49
Price-to-Book 5.68
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 52.73
Resistance 3 (R3) 52.67 52.03 52.44
Resistance 2 (R2) 52.03 51.59 52.06 52.34
Resistance 1 (R1) 51.52 51.32 51.20 51.58 52.25
Pivot Point 50.88 50.88 50.73 50.91 50.88
Support 1 (S1) 50.37 50.44 50.05 50.43 49.75
Support 2 (S2) 49.73 50.17 49.76 49.66
Support 3 (S3) 49.22 49.73 49.56
Support 4 (S4) 49.28